Ask AI
Overcoming Vaccine Hesitancy

CE / CME

Overcoming Vaccine Hesitancy: From Concerns to Confidence at the Point of Care

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: maximum of 0.75 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.75 Nursing contact hour

Released: March 06, 2026

Expiration: March 05, 2027

Activity

Progress
1 2 3
Course Completed

References

  1. Jarrett C, Wilson R, O’Leary M, et al. Strategies for addressing vaccine hesitancy: a systematic review. Vaccine. 2015;33:4180-4190.
  2. MacDonald NE; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33(34):4161-4164. doi:10.1016/j.vaccine.2015.04.036.
  3. Schmid P, Rauber D, Betsch C, et al. Barriers of influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005 - 2016. PLoS One. 2017;12:e0170550.
  4. Cataldi JR, O'Leary ST. Parental vaccine hesitancy: scope, causes, and potential responses. Curr Opin Infect Dis. 2021;34:519-526. 
  5. National Weather Service. How dangerous is lightning? weather.gov/safety/lightning-odds. Accessed February 18, 2026.
  6. Duffy J, Hambidge SJ, Jackson LA, et al. Febrile seizure risk after vaccination in children one to five months of age. Pediatr Neurol. 2017;76:72-78.
  7. Brigham. What’s in vaccines? magazine.brighamandwomens.org/departments/whats-in-vaccines. Accessed February 18, 2026.
  8. UNICEF. Vaccine messaging guide. unicef.org/documents/vaccine-messaging-guide. Accessed February 18, 2026.
  9. Centers for Disease Control and Prevention. Adult immunization standards. cdc.gov/vaccines-adults/hcp/imz-standards/. Accessed February 18, 2026.
  10. Agency for Healthcare Research and Quality. The SHARE approach. ahrq.gov/sdm/share-approach/index.html. Accessed February 18, 2026.
  11. Parrish-Sprowl J, Thomson A, Johnson RD, et al. The AIMS approach: regulating receptivity in patient-provider vaccine conversations. Front Public Health. 2023 Jun 2;11:1120326. 
  12. Commonwealth of Pennsylvania. General immunization guidance. pa.gov/agencies/health/programs/immunizations/general-immunization-guidance. Accessed February 18, 2026.
  13. American Academy of Pediatrics. AAP immunization schedule. publications.aap.org/redbook/resources/15585/AAP-Immunization-Schedule. Accessed February 18, 2026.
  14. Infectious Diseases Society of America. IDSA 2025 guidelines on the use of vaccines for the prevention of seasonal COVID-19, influenza, and RSV infections in immunocompromised patients. idsociety.org/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/. Accessed February 18, 2026.
  15. American College of Physicians. Adult immunization. acponline.org/clinical-information/clinical-resources-products/adult-immunization. Accessed February 18, 2026.
  16. University of Minnesota. Vaccine Integrity Project. vaxintegrity.cidrap.umn.edu/. Accessed February 18, 2026.
  17. Li J, Liu Y, Dai J, et al. mRNA vaccines: current applications and future directions. MedComm (2020). 2025;6:e70434.
  18. DeStefano F, Shimabukuro TT. The MMR vaccine and autism. Annu Rev Virol. 2019;6:585-600.
  19. University of Minnesota. 1 in 4 US adults mistakenly believe MMR vaccine causes autism, survey reveals. cidrap.umn.edu/measles/1-4-us-adults-mistakenly-believe-mmr-vaccine-causes-autism-survey-reveals. Accessed February 18, 2026.
  20. Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009;48:456-461. 
  21. Hviid A, Hansen JV, Frisch M, et al. Measles, mumps, rubella vaccination and autism: a nationwide cohort study. Ann Intern Med. 2019;170:513-520.
  22. Centers for Disease Control and Prevention. About the Vaccine Adverse Event Reporting System (VAERS). cdc.gov/vaccine-safety-systems/vaers/index.html. Accessed February 18, 2026.
  23. Centers for Disease Control and Prevention. About V-safe. cdc.gov/vaccine-safety-systems/v-safe/index.html. Accessed February 18, 2026.
  24. Centers for Disease Control and Prevention. About the Clinical Immunization Safety Assessment (CISA) Project. cdc.gov/vaccine-safety-systems/hcp/cisa/index.html. Accessed February 18, 2026.
  25. Centers for Disease Control and Prevention. About the Vaccine Safety Datalink (VSD). cdc.gov/vaccine-safety-systems/vsd/index.html. Accessed February 18, 2026.
  26. Baker MA, Nguyen M, Cole DV, et al. Post-licensure rapid immunization safety monitoring program (PRISM) data characterization. Vaccine. 2013;31(suppl 10):K98-112.